Display options
Cite
Cummings R. Epigenetic Drug Discovery: Great Potential and Significant Challenges. Assay Drug Dev Technol. 2015;13(4):185doi: 10.1089/adt.2015.29000.rcu.
Cummings, R. (2015). Epigenetic Drug Discovery: Great Potential and Significant Challenges. Assay and drug development technologies, 13(4), 185. https://doi.org/10.1089/adt.2015.29000.rcu
Cummings, Rich. "Epigenetic Drug Discovery: Great Potential and Significant Challenges." Assay and drug development technologies vol. 13,4 (2015): 185. doi: https://doi.org/10.1089/adt.2015.29000.rcu
Cummings R. Epigenetic Drug Discovery: Great Potential and Significant Challenges. Assay Drug Dev Technol. 2015 May;13(4):185. doi: 10.1089/adt.2015.29000.rcu. PMID: 26065555.
Copy Download .nbib Format: NLM
Share it on

Assay Drug Dev Technol. 2015 May;13(4):185. doi: 10.1089/adt.2015.29000.rcu.

Epigenetic Drug Discovery: Great Potential and Significant Challenges.

Assay and drug development technologies

Rich Cummings

Affiliations

  1. Guest Editor.
  2. Lead Discovery, Constellation Pharmaceuticals , Cambridge, Massachusetts.

PMID: 26065555 DOI: 10.1089/adt.2015.29000.rcu

[No abstract available.]

MeSH terms

Publication Types